Prosecution Insights
Prosecution Insights
7 pending office actions • 5 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (14%) |
| §102 only | 1 (14%) |
| §112 only | 3 (43%) |
| No statute on record | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PUTTLITZ, KARL J | 2 | 69.1% | +18.4% |
| VAN DRUFF, SYDNEY | 1 | 57.2% | +28.5% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +11.8% |
| CANELLA, KAREN A | 1 | 62.6% | +32.9% |
| STONEBRAKER, ALYSSA RAE | 1 | 54.4% | +52.8% |
| BRAUN, MADELINE E | 1 | 68.0% | +24.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18156709 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | PUTTLITZ, KARL J | 209d overdue |
| 17622360 | A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS | PUTTLITZ, KARL J | 37d overdue |
| 17284091 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | STONEBRAKER, ALYSSA RAE | 17d overdue |
| 17426813 | A CONJUGATE OF AN AMANITA TOXIN WITH BRANCHED LINKERS | CANELLA, KAREN A | 15d overdue |
| 17390064 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | COUGHLIN, MATTHEW P | 6d |
| 18156748 | A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | VAN DRUFF, SYDNEY | 16d |
| 17256034 | A CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES | BRAUN, MADELINE E | 19d |
| Art Unit | Apps |
|---|---|
| 1643 | 2 |
| 1646 | 2 |
| 1626 | 1 |
| 1642 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18156748 | A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | VAN DRUFF, SYDNEY | 1643 | §103 | Final Rejection | 16d | Pending | Jan 19, 2023 |
| 18156709 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | PUTTLITZ, KARL J | 1646 | Other | Non-Final OA | 209d overdue | Pending | Jan 19, 2023 |
| 17622360 | A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS | PUTTLITZ, KARL J | 1646 | §112 | Non-Final OA | 37d overdue | Pending | Dec 23, 2021 |
| 17390064 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | COUGHLIN, MATTHEW P | 1626 | §112 | Final Rejection | 6d | Pending | Jul 30, 2021 |
| 17426813 | A CONJUGATE OF AN AMANITA TOXIN WITH BRANCHED LINKERS | CANELLA, KAREN A | 1643 | §102 | Non-Final OA | 15d overdue | Pending | Jul 29, 2021 |
| 17284091 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | STONEBRAKER, ALYSSA RAE | 1642 | Other | Non-Final OA | 17d overdue | Pending | Apr 09, 2021 |
| 17256034 | A CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES | BRAUN, MADELINE E | 1624 | §112 | Final Rejection | 19d | Pending | Dec 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial